LAWRENCE A KENYON Insider Trading $OTLKW Outlook Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LAWRENCE A KENYON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LAWRENCE A KENYON. LAWRENCE A KENYON is CFO & Secretary in NEOPHARM INC ($NEOL) and CFO and Secretary in NEOPHARM INC ($NEOL) and CEO, Pres, CFO, Treas & Secy in Oncobiologics, Inc. ($ONS) and CFO and Secretary in Oncobiologics, Inc. ($ONS).
LAWRENCE A KENYON in Outlook Therapeutics, Inc.
Trading Symbol: OTLKWIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of LAWRENCE A KENYON: CEO, Pres, CFO, Treas & Secy, CFO and Secretary
Holdings: 18,926 shares
Current Value: $63,213
Latest Transaction: Apr 20 2021
$OTLKW Market Capitalization: $76.86M
$OTLKW Previous Close: $3.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LAWRENCE A KENYON in Outlook Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2021 | OTLKW | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Buy | P | 1.83 | 10,000 | 18,300 | 18,926 | 8.9 K to 18.9 K (+112.03 %) |
Jul 21 2020 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.58 | 450,000 | 711,000 | 450,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 0.54 | 216,435 | 116,875 | 216,435 | |
Sep 23 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Sell | S | 1.70 | 1,350 | 2,295 | 80,863 | 82.2 K to 80.9 K (-1.64 %) |
Sep 13 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.75 | 450,000 | 787,500 | 450,000 | |
Feb 19 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.32 | 800,000 | 1,056,000 | 800,000 | |
Feb 08 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Buy | P | 0.90 | 25,000 | 22,380 | 82,213 | 57.2 K to 82.2 K (+43.70 %) |
Sep 18 2018 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Sell | S | 0.87 | 10,100 | 8,807 | 57,213 | 67.3 K to 57.2 K (-15.00 %) |
Aug 03 2018 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 0.86 | 500,000 | 430,000 | 500,000 | |
Dec 26 2017 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CFO and Secretary | Sell | S | 1.13 | 26,165 | 29,566 | 67,313 | 93.5 K to 67.3 K (-27.99 %) |
Dec 22 2016 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CFO and Secretary | Grant | A | 0.00 | 50,000 | 0 | 93,478 | 43.5 K to 93.5 K (+115.00 %) |
Page: 1